To better define the identity of SMARCA4-mutant SCLC-Y tumors, we established a panel of SCLC xenograft models derived from cell lines representative of all SCLC transcriptional subtypes, including three SMARCA4-mutant SCLC-Y lines. Here, SMARCA4 is linked to small cell lung carcinoma.